Maki Tanaka - Concepedia

Author

Maki Tanaka

Also Known As

M Tanaka, M. TANAKA, M. Tanaka, MAKI TANAKA, Maki Nabatame Katsuaki Tanaka, Maki TANAKA, Maki Tanaka, Masako TANAKA, Motoki TANAKA, Richard Ungerleider

329

Publications

Citations

H-Index

164

Concepts

All Affiliations

Kurume University Sapporo Medical University Takara (Japan)Kurume University Medical Center Nagoya University

About

Maki Tanaka is an author at Kurume University specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	52	2.2K
2	Health Sciences	13	15	1K
3	Natural Sciences	2	2	48
4	Public Health	2	2	36
5	Engineering	1	1	22

Maki Tanaka

106

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial Miguel Martín, Frankie A. Holmes, Bent Ejlertsen, The Lancet Oncology 5-Year AnalysisBreast OncologyOncologyHealth SciencesClinical Trials	2017	578
c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases. Hiroya Takeuchi, Anton J. Bilchik, Sukamal Saha, PubMed	2003	234
CCL21 Chemokine Regulates Chemokine Receptor CCR7 Bearing Malignant Melanoma Cells Hiroya Takeuchi, Akihide Fujimoto, Maki Tanaka, Clinical Cancer Research	2004	173
A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer Yoshiki Hirooka, Hideki Kasuya, Takuya Ishikawa, BMC Cancer	2018	148
Tumor-infiltrating lymphocytes are important pathologic predictors for neoadjuvant chemotherapy in patients with breast cancer Rin Yamaguchi, Maki Tanaka, Ayako Yano, Human Pathology Tumor ImmunologyBreast OncologyCancer ImmunosurveillanceMedicineImmunology	2012	141
Ex Vivo Large‐Scale Generation of Human Platelets from Cord Blood CD34 <sup>+</sup> Cells Takuya Matsunaga, Ikuta Tanaka, Masayoshi Kobune, Stem Cells	2006	128
Combination therapy of an anticancer drug with the FNIII14 peptide of fibronectin effectively overcomes cell adhesion-mediated drug resistance of acute myelogenous leukemia Takuya Matsunaga, Fumio Fukai, Shigetoshi Miura, Leukemia MedicineCell AdhesionFniii14 PeptidePeptide TherapeuticCell-matrix Interaction	2007	99
Superoxide dismutase in SAS human tongue carcinoma cell line is a factor defining invasiveness and cell motility. Hirohito Muramatsu, Katsuhisa Kogawa, Maki Tanaka, PubMed PathologyCell ProliferationCancer BiologyTumor BiologyOxidative Stress	1995	94
Objectively evaluated physical activity and sedentary time in primary school children by gender, grade and types of physical education lessons Chiaki Tanaka, Maki Tanaka, Shigeho Tanaka BMC Public Health	2018	72
Increased systemic levels of inflammatory mediators following one‐stage full‐mouth scaling and root planing Toshiya Morozumi, Akihiro Yashima, Kazuhiro Gomi, Journal of Periodontal Research	2018	71

Page 1